Masimo is a leading provider of advanced noninvasive monitoring solutions, focusing on technologies that improve patient care and operational efficiency in healthcare settings. The company leverages ...
Irvine-based Masimo is being acquired by Danaher Corp. in a deal with an enterprise value of about $9.9 billion, allowing it to gain a foothold in the medical supply business. Danaher will pay $180 ...
Danaher will acquire pulse oximeter maker Masimo in a $9.9 billion deal, as the life science firm looks to bulk up its diagnostics portfolio. The companies said on Tuesday that Danaher will pay $180 ...
IRVINE, Calif., February 17, 2026--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) ("Masimo"), a leading global medical innovator, today announced that it has entered into a definitive agreement ...
WASHINGTON, Feb. 17, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo ...
While headlines celebrated the patent infringement verdict, exclusive Benzinga Edge’s Stock Rankings data reveals that Masimo's quality score has tumbled to 10.43, placing it in the bottom tier of ...
Hosted on MSN
Masimo unveils long-term strategy at investor day
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today hosted its 2025 Investor Day at the Company’s headquarters. At the event, Masimo’s management team provided an update on the Company’s long ...
Masimo (NASDAQ: MASI) today hosted its 2025 Investor Day at the Company’s headquarters. At the event, Masimo’s management team provided an update on the Company’s long-term strategy, including the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results